Cite

HARVARD Citation

    Martin-Blondel, G. et al. (2022). Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2. Journal of infection. 85 (4), pp. e104-e108. [Online]. 
  
Back to record